Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

How to: Bell Direct’s ETF filter

Bell Direct
September 5, 2020

Weekly Wrap 4 September

Jessica Amir
September 4, 2020

How to: Use Bell Direct’s mFund filter

Bell Direct
September 4, 2020

Morning Bell 4 September

Jessica Amir
September 4, 2020

How to: Market Map

Bell Direct
September 3, 2020

Morning Bell 3 September

Jessica Amir
September 3, 2020

How to: Unusual Volume

Bell Direct
September 2, 2020

Morning Bell 2 September

Jessica Amir
September 2, 2020

Morning Bell 1 September

Jessica Amir
September 1, 2020

Morning Bell 31 August

Jessica Amir
August 31, 2020

Weekly Wrap 28 August

Bell Direct
August 28, 2020